Besch W, Blücher H, Bettin D, Wolf E, Michaelis D, Kohnert K D
Institute of Diabetes, Gerhardt Katsch, Ernst Moritz Arndt University Greifswald, Karlsburg, Germany.
Int J Clin Lab Res. 1995;25(2):104-9. doi: 10.1007/BF02592366.
Increased erythrocyte sodium-lithium countertransport activity has been implicated in the pathogenesis of diabetic nephropathy. However, its relationship to other cation membrane transport systems in incipient nephropathy is not yet clear. The present study was thus performed to: (1) explore associations between sodium-lithium countertransport and changes in the activity of other cation transport pathways and (2) to compare the sodium transport activities with clinical characteristics of insulin-dependent diabetic patients with and without evidence of incipient diabetic nephropathy. We measured erythrocyte sodium-lithium countertransport, passive sodium/potassium flux (at 1 degree C), adenine nucleotide content in intact erythrocytes and sodium/potassium-, magnesium- and calcium-dependent ATPase activity in erythrocyte membrane preparations from 34 insulin-dependent diabetic patients without microalbuminuria, 8 diabetic patients with microalbuminuria, and 8 age-matched healthy control subjects. Sodium-lithium countertransport was elevated in diabetic patients with normo- and microalbuminuria compared with control subjects [268 +/- 99 and 299(277-465), respectively, vs. 166 +/- 65 mumol/(1 cells x h)] and was positively correlated (r = 0.36, P < 0.05) with the albumin excretion rate. However, the activity of erythrocyte membrane ATPases was significantly decreased compared with control subjects. The ATP and ADP content was found to be significantly higher (P < 0.001) in erythrocytes from diabetic patients compared with control subjects (1,196 +/- 276 vs. 833 +/- 253 mumol/l cells and 353 +/- 97 vs. 255 +/- 64 mumol/l cells, respectively). The extent of erythrocyte potassium leakage correlated with hemoglobin A1c (r = 0.39, P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
红细胞钠-锂逆向转运活性增加与糖尿病肾病的发病机制有关。然而,其在早期肾病中与其他阳离子膜转运系统的关系尚不清楚。因此,本研究旨在:(1)探讨钠-锂逆向转运与其他阳离子转运途径活性变化之间的关联;(2)比较有和无早期糖尿病肾病证据的胰岛素依赖型糖尿病患者的钠转运活性与临床特征。我们测量了34名无微量白蛋白尿的胰岛素依赖型糖尿病患者、8名有微量白蛋白尿的糖尿病患者以及8名年龄匹配的健康对照者的红细胞钠-锂逆向转运、被动钠/钾通量(1℃时)、完整红细胞中的腺嘌呤核苷酸含量以及红细胞膜制剂中钠/钾-、镁-和钙依赖性ATP酶活性。与对照者相比,有正常白蛋白尿和微量白蛋白尿的糖尿病患者的钠-锂逆向转运升高[分别为268±99和299(277 - 465),而对照者为166±65 μmol/(1个细胞×小时)],且与白蛋白排泄率呈正相关(r = 0.36,P < 0.05)。然而,与对照者相比,红细胞膜ATP酶活性显著降低。发现糖尿病患者红细胞中的ATP和ADP含量显著高于对照者(分别为1,196±276对833±253 μmol/升细胞和353±97对255±64 μmol/升细胞,P < 0.001)。红细胞钾泄漏程度与糖化血红蛋白A1c相关(r = 0.39,P < 0.05)。(摘要截取自250字)